PBM-Regulating Legislation In North Dakota Opposed By FTC
This article was originally published in The Pink Sheet Daily
Executive Summary
A bill before the North Dakota state legislature would limit PBMs’ ability to reduce prescription drug costs, Federal Trade Commission staff says in a letter to a state lawmaker. The legislation would regulate PBMs’ contracts with pharmacies and prohibit certain drug substitutions.